Posts
- Category: organization (continued)
- EHDN NEWS
- EHDN NEWS
- Enroll-HD autumn 2014 News
- European HD Network
- European Patent Office issued its intention to grant Genervon Biopharmaceuticals a European patent on Methods of Treating Neuronal Disorders using MNTF peptides and analogs thereof.
- Fathoming Huntington’s disease, genetic testing and the biotechnological era in an academic setting
- FDA End of Phase 2 Status Update
- Fear of onset: the inescapable reality of the Huntington’s disease gene carrier
- FELLOWSHIP EXCHANGE PROGRAMME 2017
- Fellowship exchange programme announces first winners
- Fighting for the option to care for Huntington’s disease patients at home
- First-time Use of SD-809-ER in HD First-HD
- Game-changers in the fight against disease: a report from the World Stem Cell Summit
- GUIDA PRATICA ALL’ALIMENTAZIONE NELLA MALATTIA DI HUNTINGTON
- HD INSIGHTS - Issue No 13 -- Winter 2016
- HDBUZZ
- Holding Onto The Value of Life In The Midst of The Perfect Storm
- Hope of clinical trials creates new, proactive outlook on Huntington’s disease
- Hope, cutting-edge science, and poignant moments at the World Congress on Huntington’s Disease
- How toxic protein aggregates develop
- Huntington’s Disease: Advocacy Driving Science -
- Junior Seau, Super Sunday, and our most important natural resource
- KineMed and CHDI Foundation Announce Study to Investigate Role of Brain Cholesterol Synthesis and Lipid Metabolism in Huntington's Disease
- Live from Jacksonville
- Make a Difference During Huntington's Disease Awareness Month, May 2012
- Making the threat of Huntington’s disease ‘small stuff’
- MEDICO E PAZIENTE CON MH: IL COMPLESSO RAPPORTO CON LA VERITÀ
- MedStar Georgetown Offers First U.S. Program for Young People Impacted by Huntington Disease
- Memories of genetic testing: from my mom to Angelina Jolie
- Moving toward a potential treatment: Isis, CHDI researchers outline upcoming Huntington’s disease gene-silencing trial
- New California stem cell chief stresses speed and efficiency in search for treatments
- News flash: Isis and Roche hope to start Huntington’s gene-silencing trial in first half of 2015
- No Marine deserted on the battlefield’: two surviving spouses join forces to speed the defeat of Huntington’s disease
- NOTIZIARIO AICH ROMA GIUGNO 2013
- Nueva diana terapéutica para el tratamiento de disfunciones cognitivas
- October 3, 2012: International Stem Cell Awareness Day
- Omeros Successfully Completes Preclinical Studies of OMS824 for Schizophrenia and Phase 1 Clinical Trial Preparations Underway
- Progress at the Scientific Planning Committee
- Pushing Scientific Boundaries:How Huntington’s research has transformed the biomedical world
- Research4HD.org founded on May 15, 2012 relaunched October 25, 2012: The first website for direct donations to Huntington’s disease Researchers, Foundations and Clinics.
- Reshaping my career and life in the face of Huntington’s disease (and a note of hope)
- Results of Auspex Pharmaceuticals' Phase 3 Registration Trial of SD-809 to be Presented at AAN Annual Meeting
- Ricerca, cura e assistenza nella Malattia di Huntington: ultimi risultati raggiunti
- Social Security Commissioner, Michael J. Astrue, announced today that the SSA is adding Juvenile Onset HD (JHD) as a Compassionate Allowance (CAL) condition!
- SPECIALE TERAPIA GENICA
- Stem Cell Agency Commits $150 Million To Develop New Therapies
- Strangling of patient in nursing home a shuddering reminder of subpar care for Huntington’s disease
- Surprising Discovery: Brain Variants of Protein Associated with Huntington's and Other Neurodegenerative Diseases Identified
- Talking as a family about HD
- The end of fear and exclusion: informing my health insurance plan about the risk of Huntington’s disease
Plugin by dagondesign.com
